For many patients dying of cancer, their last chance at survival may not yet be an option. Experimental drugs often take years to approve, and in the testing phase they are only available to a tiny group of patients. Do patients have a constitutional right to try experimental drugs?
Frank Burroughs, president, Abigail Alliance for Better Access to Developmental Drugs
Frances Miller, professor of law, Boston University School of Law
Dr. Emil Freireich, director, Adult Leukemia Research Program, University of Texas M.D. Anderson Cancer Center
Dr. Ezekiel Emanuel, chair of the Department of Bioethics for The Clinical Center at the National Institutes of Health